We previously reported that co-expression of CD14 and human TLR2 in CHO cells resulted in the recognition of two clinically important genuses of Gram-positive bacteria, Staphylococcus aureus and Streptococcus pneumoniae. 1 Although soluble peptidoglycan from S. aureus substituted for the whole organisms, the key structure for recognition of the bacterial cell wall by CD14 and TLR2 has not been elucidated. Peptidoglycan is constructed from repeating disaccharide units of N-acetylglucosamine (GlcNac) and N-acetylmuramic acid (MurNac) carrying stem-peptides. Each disaccharide unit is attached to other disaccharide units, and MurNac peptides are cross-linked with other MurNac peptides. In the highly cross-linked macromolecule, MurNac-L-Ala-D-isoGln (MDP) is a common structure to essentially all bacterial species associated with mammals and was found to be a minimum structure to have adjuvant activity. 2 Several investigators also reported that MDP was capable of inducing proinflammatory cytokines, 3,4 whereas Abehsira-Amar et al. and Nagao et al. reported that the cytokine responses in macrophages stimulated with MDP were strain-dependent and species-dependent. In their studies, peritoneal macrophages from some strains of mice, including BALA/c and C3H/HeJ, produced neither IL-1 nor TNF. 5, 6 In the present study, we exposed CHO reporter cells that were transfected with CD14 and human TLR2 to various cell wall components from Staphylococcus epidermidis. Peptidoglycan prepared by treatment with 10% trichloroacetic acid 7 was digested by S. aureus lytic We previously demonstrated that Gram-positive bacteria activated immune cells via CD14 and Tolllike receptor 2 (TLR2). Although peptidoglycan, a major constituent of the bacterial cell wall, substituted for whole organisms, the essential structure of muramylpeptides required to stimulate the cells is not clear. We further investigated the critical determinant for recognition by CD14 and TLR2. Chinese hamster ovary (CHO) fibroblasts, which do not express a functional TLR2 transcript, were transfected with TLR2 or TLR4. These cells were exposed to freeze-dried Staphylococcus epidermidis and were subsequently subjected to the pro-inflammatory transcription factor nuclear factor-κB (NF-κB)-dependent CD25 expression assay. Heterologous expression of human TLR2, but not TLR4, in CHO cells conferred immune responsiveness to freeze-dried S. epidermidis. A preparation of peptidoglycan from S. epidermidis substituted for whole organisms. Staphylococcus aureus lytic enzyme-digested product (SEPS) from peptidoglycan retained the activity, but hydrolysis of the glycan backbone in SEPS by M-1 endo-N-acetylmuramidase resulted in loss of the activity. These findings showed that cellular activation by Gram-positive cell wall components was mediated by TLR2, but not TLR4, and indicated that the glycan backbone of peptidoglycan is critical for TLR2-mediated NF-κB activation.
INTRODUCTION enzyme (SALE) to cleave the pentapeptide cross-links between neighboring stem-peptide subunits (referred to as SEPS). Then, SEPS were digested with M-1 endo-Nacetylmuramidase to hydrolyze the glycan backbone (referred to as SEPS-M). In addition to these enzymatically-digested products, a synthetic compound, MDP, was used to stimulate CHO reporter cells. We found that the glycan backbone in muramylpeptides is critical for the induction of nuclear factor-κB (NF-κB)-dependent transgene expression.
MATERIALS AND METHODS

Reagents
PBS, Ham's F-12, penicillin-streptomycin, G418 and trypsin-EDTA were obtained from GibcoBRL (Rockville, MD, USA). FBS was obtained from Biological Industry (Kibbutz Beit Haemek, Israel). Hygromycin B was obtained from Calbiochem (San Diego, CA, USA). Anti-CD25 mAb conjugated with fluorescein isothiocyanate (FITC) was obtained from Becton Dickinson (Bedford, MA, USA). MDP was obtained from Sigma (St Louis, MO, USA).
Preparation of cell wall components from S. epidermidis
S. epidermidis (ATCC 155) was cultured under the same conditions as those reported previously. 7 Cell wall components were prepared exactly as described elsewhere. 7 Briefly, the harvested cells were disrupted by a homoge-nizer and submitted to differential centrifugation. The crude cell wall fraction was purified by digestions with trypsin and pronase (cell wall preparation). Peptidoglycan was obtained by extraction with 10% trichloroacetic acid at 4°C for 18 h. A sample of peptidoglycan was incubated with SALE in 0.01 M sodium pyrophosphate solution at 37°C for 6 h. The solubilized material was then submitted to gel filtration and higher-molecular-weight fractions with high contents of free amino groups and low reducing power were pooled, concentrated, and lyophilized (SEPS). Then, SEPS was subjected to hydrolysis with the M-1 enzyme to cleave the glycan backbone, boiled for 2 min to stop the reaction, centrifuged, and applied to a connecting column of Sephadex G-50/G-25. The fractions with high contents of both free amino and reducing groups were pooled, concentrated, and lyophilized (SEPS-M). The lyophilized compounds were resuspended in PBS and stored at -20°C. Before use, the suspensions were thawed and sonicated in a Silentsonic (Sharp, Osaka, Japan) for 1 min.
Cell lines
CHO reporter cells were grown as adherent monolayers at 37°C in a 5% saturated CO 2 atmosphere, and they were passaged at least twice weekly to maintain logarithmic growth. The engineering of the CD14-expressing CHO reporter cell line CHO/CD14.elam.tac, also known as clone 3E10, has been previously described in detail. 8 This clonal line expresses surface CD25 antigen under the control of a region from the human E-selectin pomoter containing the NF-κB binding site. A CHO/CD14 reporter cell line and its LPS non-responsive derivative (clone, 7.7) were stably transfected with cDNA for human TLR2 or TLR4 as described elsewhere 9 and grown in the presence of G418 (1 mg/ml) and hygromycin B (400 U/ml).
Flow cytometry analysis of CHO transfectants
Adherent monolayers of CHO cells were plated in 24-well tissue culture dishes at a density of 1 x 10 5 cells per well. After overnight incubation, the cells were stimulated with various ligands: freeze-dried S. epidermidis (1-400 µg/ml), a cell wall preparation from S. epidermidis (1-100 µg/ml), a peptidoglycan preparation from S. epidermidis (1-100 µg/ml), SEPS (1-100 µg/ml), SEPS-M (1-100 µg/ml), and MDP (1-100 µg/ml). Following incubation for 18 h, the cells were detached from the surface with trypsin/EDTA and assessed by flow cytometry for the presence of surface CD25 as described previously. 8
RESULTS
TLR2 but not TLR4 imparts cellular activation by S. epidermidis
To examine the role of TLR2 in response to S. epidermidis, CHO/CD14 cells were transfected with human TLR2. CHO/CD14 and CHO/CD14/TLR2 cells were exposed to freeze-dried S. epidermidis for 18 h and subsequently subjected to flow cytometric analysis for NF-κB-dependent CD25 expression. While freeze-dried S. epidermidis failed to induce CD25 expression in CHO/CD14 cells at any of the doses used, 10 µg/ml of freeze-dried S. epidermidis induced slight CD25 expression in CHO/CD14/TLR2 cells, and expression was evident when the cells were stimulated with 100 µg/ml of freeze-dried S. epidermidis (Fig.  1) . Although CHO cells, which do not express a functional TLR2 transcript, express a functional mRNA encoding hamster TLR4, expression of human TLR4 may confer responsiveness to S. epidermidis. To examine this possibility, LPS-non-responsive mutant CHO/CD14 cells were transfected with human TLR2 or TLR4. Although CHO/CD14mut./TLR2 cells responded to freeze-dried S. epidermidis, CHO/CD14mut./TLR4 cells failed to respond to freeze-dried S. epidermidis.
TLR2 mediates cellular activation by purified cell wall, peptidoglycan and SEPS but not by SEPS-M and MDP
Next, we exposed CHO transfectants to the cell wall components from S. epidermidis. While peptidoglycan and SEPS induced higher levels of CD25 expression than did the purified cell wall, SEPS-M failed to induce CD25 expression in CHO/CD14mut./TLR2 cells (Fig.  2) . In contrast, none of those compounds activated CHO/ CD14mut./TLR4 cells (data not shown). Since MDP is known to be a minimum bioactive component of muramylpeptides, we exposed CHO reporter cells to MDP. Like SEPS-M, MDP activated neither CHO/CD14mut./ TLR2 nor CHO/CD14mut./TLR4 cells. Similarly, purified cell wall, peptidoglycan and SEPS activated CHO/ CD14/TLR2 cells, but SEPS-M and MDP did not.
DISCUSSION
In the present study, we demonstrated that co-expression of CD14 and human TLR2 resulted in the recognition of S. epidermidis, a Gram-positive bacterium inhabiting the surface of human skin. Although high doses of freeze-dried bacteria were needed to induce evident NF-κB activation, this finding is consistent with reports that relatively high concentrations of S. epidermidis or its cell wall components were necessary for the induction of TNF-α and IL-6 from human monocytes. 10, 11 Purified cell wall, peptidoglycan and SEPS from S. epidermidis also activated CHO/ CD14mut./TLR2 but not CHO/CD14mut./TLR4 cells. These findings demonstrated that Gram-positive bacterial cell wall components induce cellular activation through TLR2, but not TLR4. The activities of peptidoglycan and SEPS for activation of CHO/CD14mut./TLR2 cells were higher than those of the purified cell wall. This might be due to the exposure of the critical determinant by acidic treatment. However, hydrolysis of the glycan backbone of SEPS by digestion with M-1 endo-N-acetylmuramidase resulted in loss of the activity, indicating that the glycan backbone is critical for TLR2-mediated NF-κB activation. Similarly, the glycan backbone played critical roles in other innate immune recognition systems. While SEPS activated the alternative pathway of the complement system, SEPS-M failed to do so. 12 Similarly, SEPS induced serotonin liberation from rabbit blood platelets, but SEPS-M did not. 7 Although neither complement activation nor serotonin liberation depends on TLR2-mediated NF-κB activation, a similar structure can be recognized by these innate immune systems. Kengatharan et al. also reported that hydrolysis of peptidoglycan from S. aureus by the M-1 enzyme significantly attenuated the activity for induction of iNOS in the presence of IFN-γ, although a certain amount of activity remained after digestion. 13 These findings are consistent with our present results.
Induction of
In addition to SEPS-M, MDP failed to activate the cells. MDP is known to have various biological activities, including adjuvant activity 2 and necrosis-inducing activity in the guinea pig primed with Mycobacterium tuberculosis. 14 Although the exact mechanisms of these activities are unclear, Weidemann et al. and Dziarski et al. reported that MDP was able to bind to membranebound and soluble CD14. 15, 16 While we demonstrated in the present study that the glycan backbone of muramylpeptides is critical for the TLR2-mediated NF-κB activation, it is not clear whether MDP, which does not have a saccharide chain, is able to bind to TLR2. Further investigation is necessary to elucidate how relatively small components of muramylpeptides such as MDP interact with the immune system.
